Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
Tetracaine HCl 3% and Oxymetazoline HCl 0.05% is a pharmaceutical drug with 8 clinical trials. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth
Dose-Escalation Safety and Pharmacokinetic Study of K305
Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients
Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults
Clinical Trials (8)
Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth
Dose-Escalation Safety and Pharmacokinetic Study of K305
Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients
Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults
Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults
Comparison of Anesthetic Efficacy of Bilateral and Unillateral Application of Kovacaine Mist in Healthy Volunteers
Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8